Z.ai’s GLM-Legal is a legal AI model built on GLM-5.3-Flash. It scores 19.2% all-pass on Harvey’s Legal Agent Benchmark, nearly 3x its base, at $0.15 per test. Access is by application.
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no ...
Recursion announces FDA alignment for REC-4881’s Phase 3 trial in familial adenomatous polyposis, targeting crucial adenoma excision outcomes.
The Java vulnerability comes weeks after a separate major vulnerability was discovered in another popular programming ...
In the field of artificial intelligence, machine learning is a branch that uses data and algorithms to imitate human learning. It's an ongoing process in which computers can improve their accuracy ...
CISA strongly urges organizations to immediately patch the recently disclosed Oracle Java vulnerability CVE-2026-114938.
Java4Shell (CVE-2026-114938) is a critical OpenJDK Base64 decoder bug that can lead to RCE. See who’s affected, how to check ...
In What Sense is Digital Nature 'Nature'?The impact of 'nature with mass' accelerates the changes in 'nature without ...
A Beginner's Guide to the Sliding Window Algorithm with JavaScript Learn the basics of the Sliding Window algorithm in ...
A 450-task benchmark built from real CVEs shows even the best AI coding agent writes code that's both working and secure only ...
Recursion Pharmaceuticals, Inc. ( RXRX ), a clinical-stage company pioneering AI-enabled drug discovery and development, reported third-quarter results ended September 30, 2026, reflecting a narrower ...
New Phase 2 REC-4881 data presented at CGA-IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results